Microfluidics based assay device
First Claim
Patent Images
1. A method of determining the concentration of an analyte in a liquid sample, the method comprising:
- (a) combining the sample with (i) an analyte binding agent that binds the analyte and (ii) a label for use in detecting the analyte, so that the analyte binding agent, the analyte, if present in the sample, and the label form an analyte binding agent/analyte/label complex;
(b) detecting a total level of the label present in a detection area, wherein the label is present in the analyte binding agent/analyte/label complex or is uncomplexed, to provide a first reference value;
(c) removing any binding agent/analyte/label complex from the detection area;
(d) detecting a level of any uncomplexed label and unreacted label that remains in the detection area after removal of the analyte binding agent/analyte/label complexes; and
(e) determining the concentation of the analyte present in the sample, if any, by subtracting the level of uncomplexed/unreacted label from the first reference value.
10 Assignments
0 Petitions
Accused Products
Abstract
A subtractive corrective assay device and methodology, whereby ail required binding and label detection reagents are initially located within the detection zone. Application of a magnetic field is used to selectively remove bound label from the detection zone by means of paramagnetic particles. The relationship between measured label concentration before and after the application of a magnetic field within the detection zone is used to accurately measure analyte concentration within the sample.
-
Citations
12 Claims
-
1. A method of determining the concentration of an analyte in a liquid sample, the method comprising:
-
(a) combining the sample with (i) an analyte binding agent that binds the analyte and (ii) a label for use in detecting the analyte, so that the analyte binding agent, the analyte, if present in the sample, and the label form an analyte binding agent/analyte/label complex; (b) detecting a total level of the label present in a detection area, wherein the label is present in the analyte binding agent/analyte/label complex or is uncomplexed, to provide a first reference value; (c) removing any binding agent/analyte/label complex from the detection area; (d) detecting a level of any uncomplexed label and unreacted label that remains in the detection area after removal of the analyte binding agent/analyte/label complexes; and (e) determining the concentation of the analyte present in the sample, if any, by subtracting the level of uncomplexed/unreacted label from the first reference value. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)
-
Specification